Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department
This paper proposes a study on the effect of hybrid blood purification therapy based on camel nanoantibody immunoadsorbent on chronic renal failure patients in nephrology department. In this paper, the hybrid blood purification therapy based on camel nanoantibody immunoadsorbent was applied to patie...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2020/8594814 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850228444322856960 |
|---|---|
| author | Tao Ma Li Wang Xiuyong Li |
| author_facet | Tao Ma Li Wang Xiuyong Li |
| author_sort | Tao Ma |
| collection | DOAJ |
| description | This paper proposes a study on the effect of hybrid blood purification therapy based on camel nanoantibody immunoadsorbent on chronic renal failure patients in nephrology department. In this paper, the hybrid blood purification therapy based on camel nanoantibody immunoadsorbent was applied to patients with chronic renal failure, and the curative effect of the patients was studied. In order to highlight the effect, a control group was set up for comparison. In this paper, the clearance effect of small molecule toxin, middle molecular toxin, and dialysis adequacy was analyzed. This study found that the average dialysis adequacy of the control group was 1.23% and that of the experimental group was 1.26%. The dialysis adequacy of the experimental group was significantly better than that of the control group. In addition, the clearance effect of small and medium molecular toxins in the experimental group was significantly better than that in the control group. It can be seen that the hybrid blood purification therapy based on camel nanoantibody immunoadsorbent is effective in the treatment of chronic renal failure patients in the department of nephrology. Therefore, it is of great value to apply camel nanoantibody in the clinical treatment of renal failure. |
| format | Article |
| id | doaj-art-2b8094feebea426995b8a8431a127f27 |
| institution | OA Journals |
| issn | 2090-9063 2090-9071 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Chemistry |
| spelling | doaj-art-2b8094feebea426995b8a8431a127f272025-08-20T02:04:31ZengWileyJournal of Chemistry2090-90632090-90712020-01-01202010.1155/2020/85948148594814Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology DepartmentTao Ma0Li Wang1Xiuyong Li2Department of Blood Purification Center, Fuyang Second People’s Hospital, Fuyang 236000, ChinaDepartment of Nephrology, Shenzhen Longhua District People’s Hospital, Shenzhen, ChinaDepartment of Blood Purification Center, Fuyang Second People’s Hospital, Fuyang 236000, ChinaThis paper proposes a study on the effect of hybrid blood purification therapy based on camel nanoantibody immunoadsorbent on chronic renal failure patients in nephrology department. In this paper, the hybrid blood purification therapy based on camel nanoantibody immunoadsorbent was applied to patients with chronic renal failure, and the curative effect of the patients was studied. In order to highlight the effect, a control group was set up for comparison. In this paper, the clearance effect of small molecule toxin, middle molecular toxin, and dialysis adequacy was analyzed. This study found that the average dialysis adequacy of the control group was 1.23% and that of the experimental group was 1.26%. The dialysis adequacy of the experimental group was significantly better than that of the control group. In addition, the clearance effect of small and medium molecular toxins in the experimental group was significantly better than that in the control group. It can be seen that the hybrid blood purification therapy based on camel nanoantibody immunoadsorbent is effective in the treatment of chronic renal failure patients in the department of nephrology. Therefore, it is of great value to apply camel nanoantibody in the clinical treatment of renal failure.http://dx.doi.org/10.1155/2020/8594814 |
| spellingShingle | Tao Ma Li Wang Xiuyong Li Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department Journal of Chemistry |
| title | Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department |
| title_full | Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department |
| title_fullStr | Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department |
| title_full_unstemmed | Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department |
| title_short | Hybrid Blood Purification Therapy Based on Camel Nanoantibody Immunoadsorbent on Patients with Chronic Renal Failure in Nephrology Department |
| title_sort | hybrid blood purification therapy based on camel nanoantibody immunoadsorbent on patients with chronic renal failure in nephrology department |
| url | http://dx.doi.org/10.1155/2020/8594814 |
| work_keys_str_mv | AT taoma hybridbloodpurificationtherapybasedoncamelnanoantibodyimmunoadsorbentonpatientswithchronicrenalfailureinnephrologydepartment AT liwang hybridbloodpurificationtherapybasedoncamelnanoantibodyimmunoadsorbentonpatientswithchronicrenalfailureinnephrologydepartment AT xiuyongli hybridbloodpurificationtherapybasedoncamelnanoantibodyimmunoadsorbentonpatientswithchronicrenalfailureinnephrologydepartment |